Kathy Galante | VP, IR & Corporate Communications |
Glenn Sblendorio | CEO, President & Director |
Kourous Rezaei | SVP & Chief Medical Officer |
David Carroll | SVP, CFO & Treasurer |
Matthew Bannon | JPMorgan Chase & Co. |
Samantha Semenkow | Citigroup |
Good day, and welcome to the IVERIC bio's First Quarter 2019 Results Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Kathy Galante, Vice President, Investor Relations and Corporate Communications. Please go ahead.
Good morning, and welcome to IVERIC bio's First Quarter 2019 Earnings Call.